Wayback Machine
Nov DEC Jan
Previous capture 19 Next capture
2014 2015 2016
1 captures
19 Dec 15 - 19 Dec 15
sparklines
Close Help
Skip to main content

Access brought to you by: LOCKSS

Login

MD Conference Express
Advanced Search

Main menu

  • HOME
  • BROWSE BY CONFERENCE
  • BROWSE BY DISCIPLINE
    • -- All Disciplines --
    • Anesthesiology
    • Cardiology & Cardiovascular Medicine
    • Dentistry
    • Dermatology
    • Endocrinology, Diabetes & Metabolism
    • Emergency Medicine & Critical Care
    • Hematology
    • Hepatology
    • Infectious Diseases
    • Nephrology
    • Neurology
    • Nutrition
    • Obstetrics & Gynecology
    • Oncology
    • Ophthalmology
    • Orthopaedics & Sports Medicine
    • Psychiatry & Psychology
    • Pulmonary & Respiratory Medicine
    • Radiology
    • Rheumatology
    • Veterinary Medicine
  • ABOUT
    • About Us
    • International Medical Advisory Board
    • Reprints
    • Librarian resources
    • Contact us
    • Help

Neurology

  • High-Performance Neuroprosthetics: Improvements within Reach
  • Management of Acute Encephalitis
  • DECIDE: Significantly Improved Brain MRI Results with DAC HYP versus Interferon in RRMS
  • A Review of the Current Understanding and Treatment of Alzheimer's Disease
  • CARE-MS II Follow-up: Improvements with Alemtuzumab Maintained for 4 Years
  • ADVANCE Results: PEG-IFN-β-1a Decreases Disability in RRMS
  • Roles for Genetic Testing in Epilepsy
  • CARE-MS I Follow-up: Alemtuzumab Efficacy, Safety for MS Treatment Maintained for More than 4 Years
  • ADVANCE Trial: PEG-IFN-β-1a Every 2 Weeks Significantly Improved Outcomes over 2 Years in RRMS
  • Treatment with Alemtuzumab Leads to Durable Benefits in Patients with Multiple Sclerosis

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

Other Products from SAGE / CQ Press

  • SAGE Journals
  • SAGE Knowledge
  • SAGE Research Methods
  • Help
Copyright © by SAGE Publications
Online ISSN: 1559-8977